Cyclic pyrimidin-4-carboxamides as CCR2 receptor antagonists for treatment of inflammation, asthma and COPD

Details for Australian Patent Application No. 2009327127 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Ebel, Heiner; Frattini, Sara; Giovannini, Riccardo; Hoenke, Christoph; Trieselmann, Thomas; Tielmann, Patrick; Scheuerer, Stefan; Hobbie, Silke (Marie Katrin)

Agent Spruson & Ferguson

Pub. Number AU-A-2009327127

PCT Pub. Number WO2010/070032

Priority 09160416.5 15.05.09 EP; 08172336.3 19.12.08 EP

Filing date 17 December 2009

Wipo publication date 24 June 2010

International Classifications

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 407/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 471/10 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/070032 Priority application(s): WO2010/070032

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009327133-Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis

2009327122-Three-dimensionally shaped articles and process for producing the same